| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 3.80 | Intermediate level resistance | N/A | N/A | Recombinant | Details | How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. (Jan 2005) |
| Cidofovir | 2.70 | Low level resistance | N/A | N/A | Recombinant | Details | How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. (Jan 2005) |
| Foscarnet | 3.20-9.00 | Range of values between Intermediate level resistance and High level resistance | N/A | N/A | Recombinant | Details | How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. (Jan 2005) |
| Mutant | Resistances |
|---|---|
| D588E |
Ganciclovir:
|
|
Cidofovir:
|
|
|
Foscarnet:
|